+
Site Tour

EuroPCR 2023: Improving outcomes in mitral regurgitation

Francesco Maisano, Marianna Adamo, Alison Duncan, Georg Nickenig and Greg Stone discuss the role of COAPT trial evidence in reducing mitral regurgitation and securing optimal outcomes for patients. Points also discussed include patient selection, repair or replacement, and real-world registry evidence on reducing MR with TEER.

Related Videos

EuroPCR 2023: Defining the future

EuroPCR 2023: Vascular access

EuroPCR 2023: COAPT 5-year follow-up

EuroPCR 2023: Tricuspid valve

M-TEER: primary and secondary Mitral Regurgitation - cases, tips and tricks

Navitor™: Voice of the Experts Mohammed Saad

AV Valves Summit 2024 | Opening of Day 2

Navitor™: Voice of the Experts Francesco Nicolas Dumonteil

TAVI Summit 2023: Streamline implantation

Trending Controversies | AV Valves

AV VALVES 2023: Morphology

SAFETY IS A JOURNEY | J. Van der Heyden & C. Besler

TRENDING TOPICS

TAVI Webinar 1 | Key learnings for advanced TAVI

When the present unlocks the future: key learnings in TAVI for experienced operators

Treating Large annuli with 35mm Navitor Vision

Achieving optimal outcomes for treatment of large annuli with 35 mm Navitor Vision Valve

PCR Webinar on secondary mitral regurgitation

New evidence reshaping the management of secondary mitral regurgitation

CONNEXT


HUB
RELATED RESOURCES

bRIGHT study

EXPAND Study: Data overview

EuroPCR 2022: TAVI 1yr outcomes

PCR LV 2021: Navitor™ Live-in-a-box

CONNEXT


LIVE
RELATED EVENTS

Screening Transmission | Mitral focus

Case Parade | Mitral focus

AV VALVES 2023: Trending Topics – Complexity

TAVI Summit - Cardiac imaging

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline